$ORGO
Organogenesis Holdings Inc.

2023 Q3 Form 10-Q Financial Statement

#000095017023040670 Filed on August 09, 2023

View on sec.gov

Income Statement

Concept 2023 Q3 2023 Q2 2022 Q2
Revenue $108.5M $117.3M $121.4M
YoY Change -7.13% -3.36% -1.46%
Cost Of Revenue $25.79M $26.32M $26.65M
YoY Change -1.48% -1.26% -10.98%
Gross Profit $82.74M $91.00M $94.75M
YoY Change -8.76% -3.96% 1.6%
Gross Profit Margin 76.24% 77.57% 78.05%
Selling, General & Admin $64.22M $70.32M $72.61M
YoY Change -19.04% -3.16% 16.46%
% of Gross Profit 77.62% 77.27% 76.63%
Research & Development $10.47M $10.94M $10.21M
YoY Change 9.35% 7.18% 39.41%
% of Gross Profit 12.65% 12.02% 10.77%
Depreciation & Amortization $2.544M $2.228M $2.749M
YoY Change 74.73% -18.95% 19.06%
% of Gross Profit 3.07% 2.45% 2.9%
Operating Expenses $74.69M $81.26M $82.81M
YoY Change -15.98% -1.88% 18.87%
Operating Profit $8.050M $9.745M $11.94M
YoY Change 352.5% -18.35% -49.4%
Interest Expense $444.0K $594.0K -$730.0K
YoY Change -22.38% -181.37% -69.97%
% of Operating Profit 5.52% 6.1% -6.12%
Other Income/Expense, Net -$413.0K -$566.0K -$21.00K
YoY Change -27.16% 2595.24% -216.67%
Pretax Income $7.637M $9.179M $11.18M
YoY Change 530.12% -17.93% -47.18%
Income Tax $4.470M $3.863M $2.440M
% Of Pretax Income 58.53% 42.09% 21.82%
Net Earnings $3.167M $5.316M $8.744M
YoY Change 1373.02% -39.2% -57.73%
Net Earnings / Revenue 2.92% 4.53% 7.2%
Basic Earnings Per Share $0.02 $0.04 $0.07
Diluted Earnings Per Share $0.02 $0.04 $65.94K
COMMON SHARES
Basic Shares Outstanding 131.3M 131.3M 129.6M
Diluted Shares Outstanding 133.4M 133.1M 132.6M

Balance Sheet

Concept 2023 Q3 2023 Q2 2022 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $98.20M $88.92M $112.3M
YoY Change -8.44% -20.81% 25.05%
Cash & Equivalents $98.23M $88.92M $112.9M
Short-Term Investments
Other Short-Term Assets $10.20M $8.539M $7.205M
YoY Change 86.2% 18.51% 1.48%
Inventory $27.91M $25.36M $23.24M
Prepaid Expenses $9.567M $7.948M
Receivables $89.28M $93.62M $88.82M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $225.6M $216.4M $231.5M
YoY Change -2.15% -6.52% 14.76%
LONG-TERM ASSETS
Property, Plant & Equipment $117.5M $111.8M $139.2M
YoY Change 21.12% -19.64% 44.54%
Goodwill $28.77M $28.77M
YoY Change 0.0%
Intangibles $17.10M $18.33M
YoY Change -22.3%
Long-Term Investments
YoY Change
Other Assets $1.321M $1.393M $33.66M
YoY Change -16.87% -95.86% 5302.73%
Total Long-Term Assets $237.1M $233.9M $224.8M
YoY Change 4.55% 4.03% 46.17%
TOTAL ASSETS
Total Short-Term Assets $225.6M $216.4M $231.5M
Total Long-Term Assets $237.1M $233.9M $224.8M
Total Assets $462.6M $450.3M $456.4M
YoY Change 1.18% -1.32% 28.35%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $26.78M $27.39M $36.37M
YoY Change -29.43% -24.7% 35.78%
Accrued Expenses $34.99M $27.78M $48.26M
YoY Change 2.43% -42.43% 55.07%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $6.700M $5.689M $3.596M
YoY Change 33.89% 58.2% -86.5%
Total Short-Term Liabilities $81.48M $73.46M $88.23M
YoY Change -8.73% -16.75% 4.36%
LONG-TERM LIABILITIES
Long-Term Debt $64.30M $63.89M $68.97M
YoY Change -4.88% -7.36% 21.33%
Other Long-Term Liabilities $1.191M $1.190M $44.77M
YoY Change 9.27% -97.34% 27.0%
Total Long-Term Liabilities $1.191M $1.190M $113.7M
YoY Change 9.27% -98.95% 23.5%
TOTAL LIABILITIES
Total Short-Term Liabilities $81.48M $73.46M $88.23M
Total Long-Term Liabilities $1.191M $1.190M $113.7M
Total Liabilities $185.8M $179.0M $202.0M
YoY Change -7.55% -11.36% 14.34%
SHAREHOLDERS EQUITY
Retained Earnings -$40.40M -$43.57M
YoY Change -23.46%
Common Stock $317.3M $314.9M
YoY Change 2.64%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $276.9M $271.3M $254.4M
YoY Change
Total Liabilities & Shareholders Equity $462.6M $450.3M $456.4M
YoY Change 1.18% -1.32% 28.35%

Cashflow Statement

Concept 2023 Q3 2023 Q2 2022 Q2
OPERATING ACTIVITIES
Net Income $3.167M $5.316M $8.744M
YoY Change 1373.02% -39.2% -57.73%
Depreciation, Depletion And Amortization $2.544M $2.228M $2.749M
YoY Change 74.73% -18.95% 19.06%
Cash From Operating Activities $16.73M $8.646M $10.20M
YoY Change 206.8% -15.19% -42.27%
INVESTING ACTIVITIES
Capital Expenditures $5.980M $7.499M -$6.168M
YoY Change -157.49% -221.58% 42.45%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities -$5.980M -$7.499M -$6.168M
YoY Change -42.51% 21.58% 36.76%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $1.751M
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -1.440M -1.054M 415.0K
YoY Change -5638.46% -353.98% -151.94%
NET CHANGE
Cash From Operating Activities 16.73M 8.646M 10.20M
Cash From Investing Activities -5.980M -7.499M -6.168M
Cash From Financing Activities -1.440M -1.054M 415.0K
Net Change In Cash 9.310M 93.00K 4.442M
YoY Change -289.11% -97.91% -64.04%
FREE CASH FLOW
Cash From Operating Activities $16.73M $8.646M $10.20M
Capital Expenditures $5.980M $7.499M -$6.168M
Free Cash Flow $10.75M $1.147M $16.36M
YoY Change -32.2% -92.99% -25.59%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Entity Central Index Key
EntityCentralIndexKey
0001661181
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2023Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2022Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2023Q2 us-gaap Preferred Stock Value
PreferredStockValue
CY2022Q4 us-gaap Preferred Stock Value
PreferredStockValue
us-gaap Accounting Standards Update Extensible List
AccountingStandardsUpdateExtensibleList
http://fasb.org/us-gaap/2023#AccountingStandardsUpdate201613Member
us-gaap Accounting Standards Update Extensible List
AccountingStandardsUpdateExtensibleList
http://fasb.org/us-gaap/2023#AccountingStandardsUpdate201613Member
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2023-06-30
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-37906
dei Entity Registrant Name
EntityRegistrantName
ORGANOGENESIS HOLDINGS INC.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
98-1329150
dei Entity Address Address Line1
EntityAddressAddressLine1
85 Dan Road
dei Entity Address City Or Town
EntityAddressCityOrTown
Canton
dei Entity Address State Or Province
EntityAddressStateOrProvince
MA
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
02021
dei City Area Code
CityAreaCode
781
dei Local Phone Number
LocalPhoneNumber
575-0775
dei Security12b Title
Security12bTitle
Class A Common Stock, $0.0001 par value
dei Trading Symbol
TradingSymbol
ORGO
dei Security Exchange Name
SecurityExchangeName
NASDAQ
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Accelerated Filer
dei Entity Small Business
EntitySmallBusiness
false
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2023Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
131311852
CY2023Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
88917000
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
102478000
CY2023Q2 us-gaap Restricted Cash Current
RestrictedCashCurrent
591000
CY2022Q4 us-gaap Restricted Cash Current
RestrictedCashCurrent
812000
CY2023Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
93615000
CY2022Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
89450000
CY2023Q2 us-gaap Inventory Net
InventoryNet
25364000
CY2022Q4 us-gaap Inventory Net
InventoryNet
24783000
CY2023Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
7948000
CY2022Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
5086000
CY2023Q2 us-gaap Assets Current
AssetsCurrent
216435000
CY2022Q4 us-gaap Assets Current
AssetsCurrent
222609000
CY2023Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
111825000
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
102463000
CY2023Q2 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
18330000
CY2022Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
20789000
CY2023Q2 us-gaap Goodwill
Goodwill
28772000
CY2022Q4 us-gaap Goodwill
Goodwill
28772000
CY2023Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
43544000
CY2022Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
43192000
CY2023Q2 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
30014000
CY2022Q4 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
30014000
CY2023Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
1393000
CY2022Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
1520000
CY2023Q2 us-gaap Assets
Assets
450313000
CY2022Q4 us-gaap Assets
Assets
449359000
CY2023Q2 us-gaap Secured Debt Current
SecuredDebtCurrent
5480000
CY2022Q4 us-gaap Secured Debt Current
SecuredDebtCurrent
4538000
CY2023Q2 us-gaap Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
209000
CY2023Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
12592000
CY2022Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
11708000
CY2023Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
27390000
CY2022Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
32330000
CY2023Q2 orgo Accrued Expenses And Other Current Liabilities
AccruedExpensesAndOtherCurrentLiabilities
27784000
CY2022Q4 orgo Accrued Expenses And Other Current Liabilities
AccruedExpensesAndOtherCurrentLiabilities
26447000
CY2023Q2 us-gaap Liabilities Current
LiabilitiesCurrent
73455000
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
75023000
CY2023Q2 us-gaap Secured Long Term Debt
SecuredLongTermDebt
63489000
CY2022Q4 us-gaap Secured Long Term Debt
SecuredLongTermDebt
66231000
CY2023Q2 us-gaap Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
402000
CY2023Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
40495000
CY2022Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
41314000
CY2023Q2 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
1190000
CY2022Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
1122000
CY2023Q2 us-gaap Liabilities
Liabilities
179031000
CY2022Q4 us-gaap Liabilities
Liabilities
183690000
CY2023Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2022Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2023Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000
CY2022Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000
CY2023Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2022Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2023Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2023Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
400000000
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
400000000
CY2023Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
132040400
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
131647677
CY2023Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
131311852
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
130919129
CY2023Q2 us-gaap Common Stock Value
CommonStockValue
13000
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
13000
CY2023Q2 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
314838000
CY2022Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
310957000
CY2023Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-43569000
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-45301000
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
271282000
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
265669000
CY2023Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
450313000
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
449359000
CY2023Q2 us-gaap Revenues
Revenues
117316000
CY2022Q2 us-gaap Revenues
Revenues
121401000
us-gaap Revenues
Revenues
224958000
us-gaap Revenues
Revenues
218518000
CY2023Q2 us-gaap Cost Of Revenue
CostOfRevenue
26316000
CY2022Q2 us-gaap Cost Of Revenue
CostOfRevenue
26652000
us-gaap Cost Of Revenue
CostOfRevenue
52923000
us-gaap Cost Of Revenue
CostOfRevenue
51732000
CY2023Q2 us-gaap Gross Profit
GrossProfit
91000000
CY2022Q2 us-gaap Gross Profit
GrossProfit
94749000
us-gaap Gross Profit
GrossProfit
172035000
us-gaap Gross Profit
GrossProfit
166786000
CY2023Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
70317000
CY2022Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
72609000
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
144151000
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
136187000
CY2023Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
10938000
CY2022Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
10205000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
22140000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
18792000
CY2023Q2 us-gaap Operating Expenses
OperatingExpenses
81255000
CY2022Q2 us-gaap Operating Expenses
OperatingExpenses
82814000
us-gaap Operating Expenses
OperatingExpenses
166291000
us-gaap Operating Expenses
OperatingExpenses
154979000
CY2023Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
9745000
CY2022Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
11935000
us-gaap Operating Income Loss
OperatingIncomeLoss
5744000
us-gaap Operating Income Loss
OperatingIncomeLoss
11807000
CY2023Q2 us-gaap Interest Expense
InterestExpense
594000
CY2022Q2 us-gaap Interest Expense
InterestExpense
730000
us-gaap Interest Expense
InterestExpense
1243000
us-gaap Interest Expense
InterestExpense
1467000
CY2023Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
28000
CY2022Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-21000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
51000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-24000
CY2023Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-566000
CY2022Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-751000
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-1192000
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-1491000
CY2023Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
9179000
CY2022Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
11184000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
4552000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
10316000
CY2023Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
3863000
CY2022Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
2440000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
2205000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
2485000
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
5316000
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
8744000
us-gaap Net Income Loss
NetIncomeLoss
2347000
us-gaap Net Income Loss
NetIncomeLoss
7831000
CY2023Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.04
CY2022Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.07
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.02
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.06
CY2023Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.04
CY2022Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.07
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.02
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.06
CY2023Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
131293398
CY2022Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
129635682
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
131189405
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
129214541
CY2023Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
133066010
CY2022Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
132600579
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
132475908
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
132705206
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
263701000
CY2023Q2 us-gaap Restricted Stock Value Shares Issued Net Of Tax Withholdings
RestrictedStockValueSharesIssuedNetOfTaxWithholdings
-34000
CY2023Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
2299000
CY2023Q2 us-gaap Profit Loss
ProfitLoss
5316000
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
271282000
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
265669000
us-gaap Restricted Stock Value Shares Issued Net Of Tax Withholdings
RestrictedStockValueSharesIssuedNetOfTaxWithholdings
-332000
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
4213000
us-gaap Profit Loss
ProfitLoss
2347000
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
271282000
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
241528000
CY2022Q2 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
-1751000
CY2022Q2 us-gaap Restricted Stock Value Shares Issued Net Of Tax Withholdings
RestrictedStockValueSharesIssuedNetOfTaxWithholdings
-158000
CY2022Q2 us-gaap Stock Issued During Period Value Acquisitions
StockIssuedDuringPeriodValueAcquisitions
828000
CY2022Q2 us-gaap Stock Issued During Period Value Acquisitions
StockIssuedDuringPeriodValueAcquisitions
828000
CY2022Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1692000
CY2022Q2 us-gaap Profit Loss
ProfitLoss
8744000
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
254385000
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
241335000
us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
-2042000
us-gaap Restricted Stock Value Shares Issued Net Of Tax Withholdings
RestrictedStockValueSharesIssuedNetOfTaxWithholdings
-646000
us-gaap Stock Issued During Period Value Acquisitions
StockIssuedDuringPeriodValueAcquisitions
828000
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
2995000
us-gaap Profit Loss
ProfitLoss
7831000
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
254385000
us-gaap Profit Loss
ProfitLoss
2347000
us-gaap Profit Loss
ProfitLoss
7831000
us-gaap Depreciation
Depreciation
4922000
us-gaap Depreciation
Depreciation
2875000
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
2459000
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
2442000
us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
3893000
us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
3649000
orgo Non Cash Interest Expense
NonCashInterestExpense
215000
orgo Non Cash Interest Expense
NonCashInterestExpense
217000
orgo Deferred Interest Expense
DeferredInterestExpense
245000
orgo Deferred Interest Expense
DeferredInterestExpense
291000
us-gaap Provision For Other Credit Losses
ProvisionForOtherCreditLosses
190000
us-gaap Provision For Other Credit Losses
ProvisionForOtherCreditLosses
122000
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-65000
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-196000
orgo Adjustment For Excess And Obsolete Inventories
AdjustmentForExcessAndObsoleteInventories
-3464000
orgo Adjustment For Excess And Obsolete Inventories
AdjustmentForExcessAndObsoleteInventories
-5228000
us-gaap Share Based Compensation
ShareBasedCompensation
4213000
us-gaap Share Based Compensation
ShareBasedCompensation
2995000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
4970000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
6485000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
4045000
us-gaap Revenues
Revenues
224958000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
3441000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
2874000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
1839000
orgo Increase Decrease In Amortization Of Lease Liabilities
IncreaseDecreaseInAmortizationOfLeaseLiabilities
4178000
orgo Increase Decrease In Amortization Of Lease Liabilities
IncreaseDecreaseInAmortizationOfLeaseLiabilities
3472000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-3535000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
2671000
orgo Increase Decrease In Accrued Liabilities And Other Current Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherCurrentLiabilities
1091000
orgo Increase Decrease In Accrued Liabilities And Other Current Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherCurrentLiabilities
-1697000
us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
67000
us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
23000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
3569000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
11606000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
15061000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
12840000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-15061000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-12840000
us-gaap Repayments Of Secured Debt
RepaymentsOfSecuredDebt
1875000
us-gaap Repayments Of Secured Debt
RepaymentsOfSecuredDebt
938000
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
332000
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
646000
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
2042000
us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
83000
us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
200000
orgo Payments Of Deferred Acquisition Consideration
PaymentsOfDeferredAcquisitionConsideration
608000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-2290000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-350000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-13782000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-1584000
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
103290000
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
114528000
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
89508000
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
112944000
us-gaap Interest Paid Net
InterestPaidNet
2608000
us-gaap Interest Paid Net
InterestPaidNet
1041000
us-gaap Income Taxes Paid
IncomeTaxesPaid
3022000
us-gaap Income Taxes Paid
IncomeTaxesPaid
974000
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
1882000
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
6546000
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
4253000
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
364000
orgo Shares Issued For Deferred Acquisition Consideration
SharesIssuedForDeferredAcquisitionConsideration
828000
us-gaap Number Of Reportable Segments
NumberOfReportableSegments
1
us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1
CY2023Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-43569000
CY2023Q2 orgo Working Capital
WorkingCapital
142980000
CY2023Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
88917000
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
122000
CY2023Q2 orgo Allowance For Doubtful Accounts Receivable Write Offs1
AllowanceForDoubtfulAccountsReceivableWriteOffs1
-217000
us-gaap Net Income Loss
NetIncomeLoss
2347000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
3569000
us-gaap Use Of Estimates
UseOfEstimates
<p style="margin-left:4.533%;text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Use of Estimates</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities at the date of the financial statements and the reported results of operations during the reporting periods. In preparing the condensed consolidated financial statements, the estimates and assumptions that management consider to be significant and that present the greatest amount of uncertainty include: revenue recognition; sales returns and credit losses; inventory reserve; recognition and measurement of current and deferred income tax assets and liabilities; the assessment of recoverability of long-lived and indefinite lived assets (including intangible assets); assessing impairment of goodwill; and</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> the valuation and recognition of stock-based compensation. Actual results and outcomes may differ significantly from those estimates and assumptions.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p style="margin-left:4.533%;text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Concentration of Credit Risk</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Financial instruments that potentially subject the Company to concentration of credit risk consist of cash and cash equivalents. The Company invests its cash equivalents in highly rated money market funds. Deposits may exceed federally insured limits, and the Company is exposed to credit risk on deposits in the event of default by the financial institutions to the extent account balances exceed the amount insured by the Federal Deposit Insurance Corporation (“FDIC”). However, the Company mitigates the risk by sweeping cash daily overnight and diversifies among financial institutions to reduce such exposure.</span></p>
CY2020Q3 us-gaap Business Combination Contingent Consideration Liability Noncurrent
BusinessCombinationContingentConsiderationLiabilityNoncurrent
3782000
CY2022Q2 us-gaap Business Combination Contingent Consideration Liability Noncurrent
BusinessCombinationContingentConsiderationLiabilityNoncurrent
0
CY2023Q2 orgo Group Purchase Organization Rebate
GroupPurchaseOrganizationRebate
1466000
CY2022Q2 orgo Group Purchase Organization Rebate
GroupPurchaseOrganizationRebate
2334000
orgo Group Purchase Organization Rebate
GroupPurchaseOrganizationRebate
2890000
orgo Group Purchase Organization Rebate
GroupPurchaseOrganizationRebate
3953000
CY2023Q2 us-gaap Revenues
Revenues
117316000
CY2022Q2 us-gaap Revenues
Revenues
121401000
us-gaap Revenues
Revenues
224958000
us-gaap Revenues
Revenues
218518000
CY2020Q3 us-gaap Business Combination Contingent Consideration Liability Noncurrent
BusinessCombinationContingentConsiderationLiabilityNoncurrent
3782000
CY2021Q3 us-gaap Business Combination Contingent Consideration Liability Noncurrent
BusinessCombinationContingentConsiderationLiabilityNoncurrent
0
CY2023Q2 us-gaap Accounts Receivable Gross Current
AccountsReceivableGrossCurrent
100266000
CY2022Q4 us-gaap Accounts Receivable Gross Current
AccountsReceivableGrossCurrent
95812000
CY2023Q2 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
6651000
CY2022Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
6362000
CY2023Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
93615000
CY2022Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
89450000
CY2023Q1 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
6921000
CY2022Q1 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
5127000
CY2022Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
6362000
CY2021Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
5153000
CY2023Q2 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
-53000
CY2022Q2 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
82000
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
190000
CY2022Q2 orgo Allowance For Doubtful Accounts Receivable Write Offs1
AllowanceForDoubtfulAccountsReceivableWriteOffs1
-187000
orgo Allowance For Doubtful Accounts Receivable Write Offs1
AllowanceForDoubtfulAccountsReceivableWriteOffs1
-516000
orgo Allowance For Doubtful Accounts Receivable Write Offs1
AllowanceForDoubtfulAccountsReceivableWriteOffs1
-253000
CY2023Q2 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
6651000
CY2022Q2 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
5022000
CY2023Q2 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
6651000
CY2022Q2 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
5022000
CY2023Q2 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
13274000
CY2022Q4 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
12282000
CY2023Q2 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
1717000
CY2022Q4 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
1022000
CY2023Q2 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
10373000
CY2022Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
11479000
CY2023Q2 us-gaap Inventory Net
InventoryNet
25364000
CY2022Q4 us-gaap Inventory Net
InventoryNet
24783000
CY2023Q2 orgo Inventory Reserve And Obsolence Charged To Cost Of Goods Sold
InventoryReserveAndObsolenceChargedToCostOfGoodsSold
2057000
CY2022Q2 orgo Inventory Reserve And Obsolence Charged To Cost Of Goods Sold
InventoryReserveAndObsolenceChargedToCostOfGoodsSold
3023000
orgo Inventory Reserve And Obsolence Charged To Cost Of Goods Sold
InventoryReserveAndObsolenceChargedToCostOfGoodsSold
3464000
orgo Inventory Reserve And Obsolence Charged To Cost Of Goods Sold
InventoryReserveAndObsolenceChargedToCostOfGoodsSold
5228000
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
2459000
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
2442000
CY2023Q2 orgo Prepaid Subscription
PrepaidSubscription
4389000
CY2022Q4 orgo Prepaid Subscription
PrepaidSubscription
4211000
CY2023Q2 us-gaap Prepaid Advertising
PrepaidAdvertising
489000
CY2022Q4 us-gaap Prepaid Advertising
PrepaidAdvertising
106000
CY2023Q2 orgo Prepaid Deposits
PrepaidDeposits
1157000
CY2022Q4 orgo Prepaid Deposits
PrepaidDeposits
635000
CY2023Q2 us-gaap Prepaid Insurance
PrepaidInsurance
1862000
CY2022Q4 us-gaap Prepaid Insurance
PrepaidInsurance
54000
CY2023Q2 us-gaap Other Prepaid Expense Current
OtherPrepaidExpenseCurrent
51000
CY2022Q4 us-gaap Other Prepaid Expense Current
OtherPrepaidExpenseCurrent
80000
CY2023Q2 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
7948000
CY2022Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
5086000
CY2023Q2 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
118941000
CY2022Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
99697000
CY2023Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
67717000
CY2022Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
62798000
CY2023Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
111825000
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
102463000
CY2023Q2 us-gaap Depreciation
Depreciation
2228000
CY2022Q2 us-gaap Depreciation
Depreciation
1528000
us-gaap Depreciation
Depreciation
4922000
us-gaap Depreciation
Depreciation
2875000
CY2023Q2 us-gaap Goodwill
Goodwill
28772000
CY2022Q4 us-gaap Goodwill
Goodwill
28772000
CY2023Q2 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
58523000
CY2023Q2 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
40193000
CY2023Q2 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
18330000
CY2022Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
58523000
CY2022Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
37734000
CY2022Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
20789000
CY2023Q2 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
1229000
CY2022Q2 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
1221000
CY2023Q2 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
19466000
CY2022Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
17113000
CY2023Q2 us-gaap Accrued Royalties Current
AccruedRoyaltiesCurrent
3210000
CY2022Q4 us-gaap Accrued Royalties Current
AccruedRoyaltiesCurrent
3320000
CY2023Q2 orgo Accrued Interest On Accrued But Unpaid Lease Obligations
AccruedInterestOnAccruedButUnpaidLeaseObligations
2082000
CY2022Q4 orgo Accrued Interest On Accrued But Unpaid Lease Obligations
AccruedInterestOnAccruedButUnpaidLeaseObligations
2463000
CY2023Q2 us-gaap Taxes Payable Current
TaxesPayableCurrent
1696000
CY2022Q4 us-gaap Taxes Payable Current
TaxesPayableCurrent
2625000
CY2023Q2 orgo Accrued Litigation Current
AccruedLitigationCurrent
564000
CY2022Q4 orgo Accrued Litigation Current
AccruedLitigationCurrent
150000
CY2023Q2 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
766000
CY2022Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
776000
CY2023Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
27784000
CY2022Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
26447000
CY2023Q1 orgo Number Of Reduction In Employees
NumberOfReductionInEmployees
71
CY2023Q1 orgo Percentage Of Reduction In Employees
PercentageOfReductionInEmployees
0.07
us-gaap Severance Costs1
SeveranceCosts1
1609000
CY2023Q2 us-gaap Restructuring Reserve Accrual Adjustment1
RestructuringReserveAccrualAdjustment1
-126000
CY2022Q2 us-gaap Restructuring Charges
RestructuringCharges
643000
us-gaap Restructuring Charges
RestructuringCharges
1782000
us-gaap Restructuring Charges
RestructuringCharges
907000
CY2023Q2 us-gaap Restructuring Reserve Current
RestructuringReserveCurrent
298000
CY2022Q4 us-gaap Restructuring Reserve Current
RestructuringReserveCurrent
1192000
CY2022Q4 us-gaap Restructuring Reserve
RestructuringReserve
1192000
us-gaap Restructuring Charges
RestructuringCharges
1782000
us-gaap Payments For Restructuring
PaymentsForRestructuring
2676000
CY2023Q2 us-gaap Restructuring Reserve
RestructuringReserve
298000
CY2021Q4 us-gaap Restructuring Reserve
RestructuringReserve
3168000
us-gaap Restructuring Charges
RestructuringCharges
907000
us-gaap Payments For Restructuring
PaymentsForRestructuring
3414000
CY2022Q2 us-gaap Restructuring Reserve
RestructuringReserve
661000
CY2023Q2 us-gaap Line Of Credit
LineOfCredit
0
CY2022Q4 us-gaap Line Of Credit
LineOfCredit
0
CY2023Q2 us-gaap Secured Debt
SecuredDebt
69375000
CY2022Q4 us-gaap Secured Debt
SecuredDebt
71250000
CY2023Q2 us-gaap Debt Instrument Unamortized Discount Premium And Debt Issuance Costs Net
DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet
406000
CY2022Q4 us-gaap Debt Instrument Unamortized Discount Premium And Debt Issuance Costs Net
DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet
481000
CY2023Q2 orgo Secured Debt Net
SecuredDebtNet
68969000
CY2022Q4 orgo Secured Debt Net
SecuredDebtNet
70769000
CY2023Q2 us-gaap Long Term Debt Maturities Repayments Of Principal In Next Twelve Months
LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths
2812000
CY2023Q2 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Two
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
5625000
CY2023Q2 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Three
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree
6563000
CY2023Q2 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Four
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour
54375000
CY2023Q2 us-gaap Long Term Debt
LongTermDebt
69375000
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.51
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.5066
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice
2.51
CY2023Q2 orgo Shares Reserved For Issuance For Outstanding Options
SharesReservedForIssuanceForOutstandingOptions
9422495
CY2022Q4 orgo Shares Reserved For Issuance For Outstanding Options
SharesReservedForIssuanceForOutstandingOptions
5931742
CY2023Q2 orgo Sharesreservedforissuanceforoutstandingrestrictedstockunits
Sharesreservedforissuanceforoutstandingrestrictedstockunits
3989750
CY2022Q4 orgo Sharesreservedforissuanceforoutstandingrestrictedstockunits
Sharesreservedforissuanceforoutstandingrestrictedstockunits
1381500
CY2023Q2 orgo Shares Reserved For Issuance For Future Grant
SharesReservedForIssuanceForFutureGrant
4889579
CY2022Q4 orgo Shares Reserved For Issuance For Future Grant
SharesReservedForIssuanceForFutureGrant
11394962
CY2023Q2 us-gaap Common Stock Capital Shares Reserved For Future Issuance
CommonStockCapitalSharesReservedForFutureIssuance
18301824
CY2022Q4 us-gaap Common Stock Capital Shares Reserved For Future Issuance
CommonStockCapitalSharesReservedForFutureIssuance
18708204
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
3554528
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
1418224
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0399
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0192
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P6Y2M26D
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P6Y3M
CY2022Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice
8.03
CY2023Q2 orgo Fair Value Of Common Share
FairValueOfCommonShare
2.47
CY2022Q2 orgo Fair Value Of Common Share
FairValueOfCommonShare
7.87
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
1.32
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
3.94
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
5931042
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
5.91
CY2022 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P6Y1M20D
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
2245000
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
3554528
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
2.51
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
63075
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
8.71
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
9422495
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
4.61
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P7Y1M24D
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
6010000
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
4033237
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
4.56
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P4Y6M18D
CY2023Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
3136000
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
8264297
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice
4.67
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1
P6Y10M6D
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue
5321000
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1
3070000
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1
2029000
CY2023Q2 us-gaap Profit Loss
ProfitLoss
5316000
CY2022Q2 us-gaap Profit Loss
ProfitLoss
8744000
us-gaap Profit Loss
ProfitLoss
2347000
us-gaap Profit Loss
ProfitLoss
7831000
CY2023Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
131293398
CY2022Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
129635682
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
131189405
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
129214541
CY2023Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
133066010
CY2022Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
132600579
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
132475908
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
132705206
CY2023Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.04
CY2022Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.07
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.02
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.06
CY2023Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.04
CY2022Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.07
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.02
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.06
CY2019Q2 orgo Interest Rate On Unpaid Lease Obligations
InterestRateOnUnpaidLeaseObligations
0.0925
us-gaap Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
58000
us-gaap Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
213000
us-gaap Finance Lease Interest Expense
FinanceLeaseInterestExpense
11000
us-gaap Finance Lease Interest Expense
FinanceLeaseInterestExpense
7000
orgo Finance Lease Cost
FinanceLeaseCost
69000
orgo Finance Lease Cost
FinanceLeaseCost
220000
us-gaap Operating Lease Cost
OperatingLeaseCost
4779000
us-gaap Operating Lease Cost
OperatingLeaseCost
4808000
us-gaap Short Term Lease Cost
ShortTermLeaseCost
1491000
us-gaap Short Term Lease Cost
ShortTermLeaseCost
1391000
us-gaap Variable Lease Cost
VariableLeaseCost
3370000
us-gaap Variable Lease Cost
VariableLeaseCost
2201000
us-gaap Lease Cost
LeaseCost
9709000
us-gaap Lease Cost
LeaseCost
8620000
CY2023Q2 us-gaap Finance Lease Right Of Use Asset Before Accumulated Amortization
FinanceLeaseRightOfUseAssetBeforeAccumulatedAmortization
1867000
CY2022Q4 us-gaap Finance Lease Right Of Use Asset Before Accumulated Amortization
FinanceLeaseRightOfUseAssetBeforeAccumulatedAmortization
1174000
CY2023Q2 us-gaap Finance Lease Right Of Use Asset Accumulated Amortization
FinanceLeaseRightOfUseAssetAccumulatedAmortization
1232000
CY2022Q4 us-gaap Finance Lease Right Of Use Asset Accumulated Amortization
FinanceLeaseRightOfUseAssetAccumulatedAmortization
1174000
CY2023Q2 us-gaap Finance Lease Right Of Use Asset
FinanceLeaseRightOfUseAsset
635000
CY2023Q1 us-gaap Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
611000
us-gaap Operating Lease Payments
OperatingLeasePayments
5059000
us-gaap Operating Lease Payments
OperatingLeasePayments
4630000
us-gaap Finance Lease Interest Payment On Liability
FinanceLeaseInterestPaymentOnLiability
11000
us-gaap Finance Lease Interest Payment On Liability
FinanceLeaseInterestPaymentOnLiability
7000
us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
83000
us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
200000
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
4253000
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
364000
us-gaap Right Of Use Asset Obtained In Exchange For Finance Lease Liability
RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability
693000
CY2023Q2 us-gaap Finance Lease Weighted Average Remaining Lease Term1
FinanceLeaseWeightedAverageRemainingLeaseTerm1
P2Y9M3D
CY2023Q2 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P6Y10M24D
CY2022Q4 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P7Y6M14D
CY2023Q2 us-gaap Finance Lease Weighted Average Discount Rate Percent
FinanceLeaseWeightedAverageDiscountRatePercent
0.068
CY2023Q2 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0477
CY2022Q4 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0461
CY2023Q2 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
10176000
CY2023Q2 us-gaap Finance Lease Liability Payments Remainder Of Fiscal Year
FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear
122000
CY2023Q2 us-gaap Lessee Operating Lease Liability Payments Due Next Rolling Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextRollingTwelveMonths
8818000
CY2023Q2 us-gaap Finance Lease Liability Payments Due In Next Rolling Twelve Months
FinanceLeaseLiabilityPaymentsDueInNextRollingTwelveMonths
244000
CY2023Q2 us-gaap Lessee Operating Lease Liability Payments Due In Rolling Year Two
LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearTwo
8938000
CY2023Q2 us-gaap Finance Lease Liability Payments Due In Rolling Year Two
FinanceLeaseLiabilityPaymentsDueInRollingYearTwo
244000
CY2023Q2 us-gaap Lessee Operating Lease Liability Payments Due In Rolling Year Three
LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearThree
7542000
CY2023Q2 us-gaap Finance Lease Liability Payments Due In Rolling Year Three
FinanceLeaseLiabilityPaymentsDueInRollingYearThree
61000
CY2023Q2 us-gaap Lessee Operating Lease Liability Payments Due In Rolling Year Four
LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearFour
8002000
CY2023Q2 us-gaap Lessee Operating Lease Liability Payments Due After Rolling Year Five
LesseeOperatingLeaseLiabilityPaymentsDueAfterRollingYearFive
18679000
CY2023Q2 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
62155000
CY2023Q2 us-gaap Finance Lease Liability Payments Due
FinanceLeaseLiabilityPaymentsDue
671000
CY2023Q2 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
9068000
CY2023Q2 us-gaap Finance Lease Liability Undiscounted Excess Amount
FinanceLeaseLiabilityUndiscountedExcessAmount
60000
CY2023Q2 us-gaap Operating Lease Liability
OperatingLeaseLiability
53087000
CY2023Q2 us-gaap Finance Lease Liability
FinanceLeaseLiability
611000
CY2023Q2 orgo Accrued Legal Expenses
AccruedLegalExpenses
564000
CY2022Q4 orgo Accrued Legal Expenses
AccruedLegalExpenses
150000
us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
2205000
orgo Discreet Tax Expense
DiscreetTaxExpense
45000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
2485000
orgo Discreet Tax Expense
DiscreetTaxExpense
23000
ecd Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
false
ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false
ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false

Files In Submission

Name View Source Status
0000950170-23-040670-index-headers.html Edgar Link pending
0000950170-23-040670-index.html Edgar Link pending
0000950170-23-040670.txt Edgar Link pending
0000950170-23-040670-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
orgo-20230630.htm Edgar Link pending
orgo-20230630.xsd Edgar Link pending
orgo-ex31_1.htm Edgar Link pending
orgo-ex31_2.htm Edgar Link pending
orgo-ex32_1.htm Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
orgo-20230630_cal.xml Edgar Link unprocessable
orgo-20230630_def.xml Edgar Link unprocessable
orgo-20230630_lab.xml Edgar Link unprocessable
orgo-20230630_pre.xml Edgar Link unprocessable
orgo-20230630_htm.xml Edgar Link completed
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R72.htm Edgar Link pending
R73.htm Edgar Link pending
R74.htm Edgar Link pending
R75.htm Edgar Link pending
R76.htm Edgar Link pending
R77.htm Edgar Link pending
R78.htm Edgar Link pending
R79.htm Edgar Link pending
R8.htm Edgar Link pending
R80.htm Edgar Link pending
R81.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending